Revolution Medicines (RVMD) Made Pancreatic-Cancer History. At $47B Valuation, the Market Already Assumed It
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Federal appeals court panel gives Nevada a win in its fight to regulate prediction market Kalshi
A federal appeals court panel on Friday refused to let prediction market operator Kalshi restart trading on sports and elections events in…
Why SSR Mining Stock Flopped on Friday
Key PointsThis was due largely to hawkish remarks from Fed chair Kevin Warsh.
